People & Careers

Home>News>People & Careers

World Ovarian Cancer Day – Insights from Board Advisor, Heather Hawkins

Today on World Ovarian Cancer Day, we are proud to share the powerful story of Heather Hawkins – ovarian cancer survivor, global marathon runner, patient advocate, and a valued Board Advisor at Cartherics.

After being diagnosed with ovarian cancer in 2007, Heather transformed her experience into a mission of awareness, action, and hope. Her survivorship, combined […]

2025-05-08T10:42:54+10:00May 8th, 2025|

Cartherics appoints new Board Chair and Non-Executive Director

  • Cartherics appoints Prof. Bryan Williams as new Board Chair and Ms. Laurence Nore as Non-Executive Director

Melbourne, Australia, 16 April 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company focused on developing immune cell therapies for cancer and other diseases, is pleased to announce the appointment of Prof. Bryan R.G. Williams […]

2025-05-08T09:47:26+10:00April 16th, 2025|

Cartherics strengthens scientific and manufacturing team

Cartherics is pleased to announce that it has made several strategic new appointments to enhance its scientific and manufacturing teams, aligning with the company’s commitment to advancing its growing pipeline of innovative therapies. These new additions are expected to bring in diverse expertise, reinforcing the company’s capabilities in both research and development as well […]

2025-03-20T14:23:43+11:00March 20th, 2025|

Message from the CEO

As we reflect on 2024, it’s clear that this year has been a defining chapter in Cartherics’ 10-year history. We’ve experienced significant milestones, overcome challenges, and made bold strides toward advancing our mission. The work on ovarian cancer has progressed with the autologous CAR-T product under preclinical evaluation by the Peter MacCallum Cancer Centre, […]

2024-12-17T13:26:48+11:00December 16th, 2024|

Cartherics’ CEO named ScholarGPS highly ranked scholar for outstanding scholarly contributions

We are pleased to announce that Cartherics’ CEO, Prof. Alan Trounson has been recognised as a ScholarGPS Highly Ranked Scholar in recognition of his exceptional scholarly performance. His impactful work and high-quality contributions have earned him a spot in the top 0.05% of 30 million scholars globally, ranking highly across seven fields. Notably, Alan is […]

2024-09-20T11:35:17+10:00September 20th, 2024|

The first baby from a frozen embryo turns 40!

Cartherics’ CEO, Prof. Alan Trounson was recently interviewed by Barbara Barkhausen, a German speaking, Asia-Pacific Correspondent for a variety of German, Austrian and Swiss newspapers. Barbara’s article, translated below, was published in a number of European newspapers, highlighting that the first baby born from a frozen embryo is now 40 years old – a result […]

2024-05-02T14:08:41+10:00May 2nd, 2024|

Cartherics appoints new Chief Scientific Officer

Melbourne, Australia, 17 October 2023 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has appointed Dr Walid Azar as Chief Scientific Officer (CSO), effective immediately. He holds extensive experience from a diverse scientific background encompassing both academic research and […]

2023-10-17T20:06:39+11:00October 17th, 2023|

Bio Connections Australia 2023 promotes science commercialisation

Commercialising science and technology is key to the continued growth of Australia’s vibrant life sciences industry. Translating research into real-world results has important implications for consumers and businesses alike.

Bio Connections Australia 2023 was held today at Crown Promenade Melbourne with an important focus on translation, drug development and expediting Australia’s science into commercialisation.

The forum […]

2023-07-31T16:08:33+10:00July 31st, 2023|

Australia – China Science and Innovation Forum fosters collaboration and commercialisation

The 2023 Australia-China Science and Innovation Forum focused on leading-edge Australian and Chinese biomedical research collaborations and commercialisation. The forum was held at Monash University’s Suzhou campus in China last week and was also available for online attendance.

The forum’s program was designed to promote connections and enhance collaborations between the Australian and Chinese research and […]

2023-06-28T11:13:35+10:00June 28th, 2023|

Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents

Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21st Advanced Summit on Life Sciences Patents in New York City. The summit provided the opportunity to engage in face-to-face discussions with leading stakeholders on the best practices to enhance global protections for patent portfolios. Now more than ever in these increasingly […]

2023-05-30T15:08:10+10:00May 30th, 2023|
Go to Top